The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $69.03

Today's change+0.59 +0.86%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $69.03

Today's change+0.59 +0.86%
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.

ResMed Inc up (U.S.)$0.59

ResMed Inc closed up Friday by (U.S.)$0.59 or 0.86% to (U.S.)$69.03. Shares have lost 1.48% over the last five days, but sit 2.64% below their 52-week high. This security has outperformed the S&P 500 by 21.46% during the last year.

Key company metrics

  • Open(U.S.) $68.74
  • Previous close(U.S.) $68.44
  • High(U.S.) $69.28
  • Low(U.S.) $68.51
  • Bid / Ask-- / --
  • YTD % change+28.57%
  • Volume1,060,316
  • Average volume (10-day)1,106,596
  • Average volume (1-month)965,362
  • Average volume (3-month)905,396
  • 52-week range(U.S.) $49.11 to (U.S.) $70.90
  • Beta0.71
  • Trailing P/E27.72×
  • P/E 1 year forward23.80×
  • Forward PEG2.28×
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield1.91%
  • Trailing EPS(U.S.) $2.49
Updated August 26 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue519454455412
Total other revenue--------
Total revenue519454455412
Gross profit301260267239
Total cost of revenue217194188173
Total operating expense400350347314
Selling / general / administrative136123118111
Research & development34282927
Depreciation / amortization13542
Interest expense (income), net operating--------
Unusual expense (income)007--
Other operating expenses, total--------
Operating income11910410898
Interest income (expense), net non-operating-11------
Gain (loss) on sale of assets--------
Other--------
Income before tax11710911499
Income after tax93889180
Income tax, total24212319
Net income93889180
Total adjustments to net income--------
Net income before extra. items93889180
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items93889180
Inc. avail. to common incl. extra. items93889180
Diluted net income93889180
Dilution adjustment0------
Diluted weighted average shares142141141142
Diluted EPS excluding extraordinary itemsvalue per share0.660.630.640.57
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share0.660.630.680.57